2-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-chloro-1h-indol-3-yl)propanoic acid, 97%, 250mg

(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-5-yl)propanamido]hexanoic acid; acetic acid, 98%, 5g

1-(4-Bromophenyl)prop-2-en-1-amine, 95.0%, 1g

1-(4-aminophenyl)-3-methylimidazolidin-2-one, 95.0%, 1g

(S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4,4-difluoro-butyric acid, 98.0%, 5g

1-Adamantanecarboxaldehyde, 95.0%, 1g

((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(di(naphthalen-1-yl)methanol), 97%, 5g

2-Oxo-1,2-dihydro-quinoline-7-sulfonyl chloride, 88.0%, 1g

5-FLUOROQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 1g

Sudan IV (C. I. 26105), 50 g

3-(1H-benzimidazol-2-yl)-1,1,1-trifluoroacetone, 95.0%, 5g

Accessories tube cups for standard tubes 15 ml, 1 piece

Ethyl(3-chloro-5-(trifluoromethyl)pyridine-2-yl)acetate, 95.0%, 1g